---
title: "Srestha Finvest Ltd (539217) — Share Price, Financials & Analysis"
symbol: "539217"
company: "Srestha Finvest Ltd"
canonical: "https://tapetide.com/stocks/539217"
isin: "INE606K01049"
nse_symbol: "SRESTHAFINVESTLTD"
bse_code: "539217"
sector: "Financial Services"
industry: "Investment Company"
market_cap_cr: 51.6
generated_at: "2026-09-13T18:37:40.018Z"
---

# Srestha Finvest Ltd (539217)

Canonical page: https://tapetide.com/stocks/539217

## Company

- **NSE Symbol:** SRESTHAFINVESTLTD
- **BSE Code:** 539217
- **ISIN:** INE606K01049
- **Sector:** Financial Services
- **Industry:** Investment Company
- **Macro Sector:** Financial Services
- **Stock Type:** EQUITY
- **Listed Since:** 2015-07-17
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** srestha.co.in

## About

Incorporated in 1985, Srestha Finvest Ltd is 
in the business of financing and investment activities.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:36:19.845992Z.

- **Market Cap:** ₹51.6 Cr
- **Classification:** Microcap
- **P/E (reported):** -1.4
- **EPS (TTM):** ₹-0.23
- **EPS (reported):** ₹0.02
- **Book Value:** ₹0.84
- **Price to Book:** 0.32
- **Dividend Yield:** 0%
- **ROE:** -4.62%
- **ROCE:** -5.65%
- **Debt to Equity:** 0.29
- **Revenue (yearly):** ₹7.9 Cr
- **Net Income:** ₹-7.6 Cr
- **EBITDA:** ₹-11.3 Cr
- **52-Week High:** ₹0.46
- **52-Week Low:** ₹0.18
- **RSI (14):** 49.03

## Tapetide Score

- **Score:** 36 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 7.3 (of 4473 scored stocks)
- **Confidence:** 91%
- **Data coverage:** 81%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 1.1 | 9% |
| growth | 17.28 | 9% |
| momentum | 48.18 | 12% |
| ownership | 50 | 24% |
| quality | 24.89 | 22% |
| valuation | 43.84 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Stock is trading at 0.26 times its book value

### Weaknesses

- Company has low interest coverage ratio.
- Company has a low return on equity of -9.76% over last 3 years.
- Working capital days have increased from 757 days to 1,630 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 61.58% | -43.78% | — |
| ebitda margin growth | -724.44% | -48.16% | -390.51% | — |
| net income growth | — | -78.35% | -22% | — |
| revenue growth | 76.92% | -30.09% | 39% | 10% |
| roce | 696.79% | -59.99% | -285.86% | — |
| roe | — | -77.68% | -8% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 2 | 3 | 6 | 40 | 4 | 3 | 1 | 4 | 1 | 1 | 1 | 1 |
| Expenses | 4 | 2 | 0 | 1 | 18 | 27 | 32 | 1 | 12 | 1 | 6 | 39 |
| Operating Profit | -2 | 1 | 6 | 38 | -15 | -24 | -31 | 3 | -11 | 1 | -5 | -38 |
| OPM % | -88 | 27 | 100 | 96 | -418 | -680 | -3280 | 84 | -898 | 59 | -351 | -3130 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Interest | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | -1 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -3 | 0 | 5 | 37 | -16 | -25 | -31 | 2 | -11 | 1 | -4 | -37 |
| Tax % | 0 | 0 | 2 | 16 | -6 | 0 | -15 | 0 | 0 | 0 | -112 | -26 |
| Net Profit | -3 | 0 | 5 | 31 | -15 | -25 | -27 | 2 | -11 | 1 | 0 | -27 |
| EPS in Rs | -0.02 | 0 | 0.03 | 0.19 | -0.09 | -0.15 | -0.16 | 0.01 | -0.07 | 0 | 0 | -0.16 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 3 | 4 | 4 | 5 | 2 | 3 | 13 | 11 | 7 | 5 |
| Expenses | 1 | 3 | 2 | 2 | 2 | 7 | 6 | 42 | 19 | 58 |
| Operating Profit | 2 | 1 | 2 | 2 | 1 | -4 | 6 | -31 | -12 | -53 |
| OPM % | 52 | 37 | 53 | 48 | 29 | -157 | 49 | -276 | -159 | -1067 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Interest | 1 | 2 | 2 | 3 | 1 | 0 | 4 | 3 | 0 | -1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Profit before tax | 0 | 0 | 0 | -1 | 0 | -5 | 2 | -35 | -12 | -51 |
| Tax % | 34 | 0 | 5 | 0 | 50 | 6 | 4 | 0 | -37 | — |
| Net Profit | 0 | 0 | 0 | -1 | 0 | -5 | 2 | -35 | -8 | -37 |
| EPS in Rs | 0.01 | -0.02 | -0.01 | -0.03 | 0 | -0.05 | 0.01 | -0.21 | -0.05 | -0.23 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 15 | 15 | 16 | 16 | 16 | 16 | 66 | 116 | 164 | 164 |
| Reserves | 3 | 3 | 1 | 0 | 0 | 0 | -5 | 19 | 5 | 0 |
| Borrowings | 6 | 18 | 22 | 30 | 29 | 9 | 30 | 50 | 48 | 48 |
| Other Liabilities | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 8 | 0 | 0 |
| Total Liabilities | 24 | 36 | 40 | 47 | 46 | 26 | 92 | 193 | 217 | 212 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 1 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 1 | 0 | 0 | 0 | 4 | 59 | 67 | 55 |
| Other Assets | 24 | 36 | 39 | 47 | 46 | 26 | 87 | 132 | 148 | 156 |
| Total Assets | 24 | 36 | 40 | 47 | 46 | 26 | 92 | 193 | 217 | 212 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -12 | 1 | 2 | -2 | 1 | -3 | -42 | -14 | -54 | -20 |
| Cash from Investing Activity | 0 | 0 | -1 | 0 | 0 | 0 | -6 | -27 | -20 | 4 |
| Cash from Financing Activity | 12 | 0 | 0 | 0 | 0 | 0 | 50 | 50 | 70 | 9 |
| Net Cash Flow | 0 | 1 | 1 | -1 | 1 | -3 | 1 | 9 | -3 | -7 |
| Free Cash Flow | -12 | 1 | 2 | -2 | 1 | -3 | -44 | -16 | -54 | -20 |
| CFO/OP | -1035 | 40 | 142 | -80 | 52 | -395 | 973 | -227 | 172 | 170 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 20 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 |
| Cash Conversion Cycle | 20 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 |
| Working Capital Days | 2541 | -33 | -36 | -32 | -12 | -5 | 982 | 176 | 466 | 1630 |
| ROCE % | 6 | 5 | 4 | 5 | 5 | 2 | -7 | 4 | -16 | -6 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| FIIs | 0% | 0% | 0% | 0% | 0.53% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 13.59% | 14.65% | 15.72% | 23.91% | 56.48% | 95.54% | 95.4% | 95.59% | 95.57% | 95.66% | 95.94% | 89.62% |
| Others | 86.41% | 85.35% | 84.28% | 76.09% | 42.99% | 4.46% | 4.6% | 4.41% | 4.43% | 4.34% | 4.06% | 10.38% |
| No. of Shareholders | 27312 | 30515 | 32129 | 49263 | 84194 | 204422 | 207809 | 200480 | 193951 | 188149 | 183235 | 179747 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 0 / 8 / 11

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 0.26 | Sell |
| EMA (10) | 0.26 | Sell |
| SMA (20) | 0.27 | Sell |
| EMA (20) | 0.27 | Sell |
| SMA (50) | 0.29 | Sell |
| EMA (50) | 0.28 | Sell |
| SMA (100) | 0.27 | Sell |
| EMA (100) | 0.28 | Sell |
| SMA (200) | 0.28 | Sell |
| EMA (200) | 0.3 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 44.08 | Neutral |
| MACD (12,26,9) | -0.01 | Sell |
| Stochastic (14,3,3) | 58.33 | Neutral |
| ADX (14) | 17.84 | Neutral |
| Williams %R (14) | -50 | Neutral |
| ATR (14) | 0.01 | High Volatility |
| ROC (12) | 0 | Neutral |
| Stoch RSI (14) | 68.75 | Neutral |
| UO (7,14,28) | 37.82 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-07 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27919156-340f-4e6c-8cda-6f7c65b2ea3c.pdf) |
| 2026-09-04 | [Intimation Under Reg 30 Of SEBI (LODR) Reg 2015 For Notice Of AGM Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38ecadb4-7931-4932-864d-5934bdb7ed3f.pdf) |
| 2026-09-04 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43863aaf-5408-4612-b5e3-8b25fe66b285.pdf) |
| 2026-09-04 | [Announcement under Regulation 30 (LODR)-Change in Directorate](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b943ee54-2754-4903-81ac-0261a5bfed0a.pdf) |
| 2026-08-18 | [Unaudited Financial Results For The Quarter Ended 30.06.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32088c29-f54d-4e52-bdd5-5909b08a5b55.pdf) |
| 2026-08-18 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cae94a38-b515-4719-8485-86e314034580.pdf) |
| 2026-08-17 | [Board Meeting Outcome for For Allotment Of Securities Upon Conversion Of Warrants](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef890125-07f2-42bb-b316-fef4491ac911.pdf) |
| 2026-08-17 | [Announcement under Regulation 30 (LODR)-Allotment](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=519c5f0d-f000-40dc-a0f9-303565d06e47.pdf) |
| 2026-08-14 | [Board Meeting Outcome for Outcome Of Board Meeting Dated 14/08/2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6bb06a3-0a24-4240-abe6-621159dd2a6a.pdf) |
| 2026-08-04 | [Board Meeting Intimation for Notice Of Board Meeting Scheduled To Be Held On August 14 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4294e504-89e6-44a4-81d7-9e8674d625b8.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-05-30 | [Audited Financial Results For The Period Ended 31/03/2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80af5ec7-6455-4d93-9fa8-2c0c56eb4072.pdf) |
| 2025-08-14 | [Results Unaudited Financial Results For June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=82461f2f-363c-44d7-8ece-4925a4a87afb.pdf) |
| 2025-07-04 | [AUDITED FINANCIAL RESULTS FOR THE PERIOD ENDED 31/03/2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ea12687-c84c-4451-a176-4e92a2e10cd1.pdf) |
| 2025-05-31 | [AUDITED FINANCIAL RESULTS FOR THE PERIOD ENDED 31/03/2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=177fae18-c099-4568-b561-a3008b902a6e.pdf) |
| 2025-05-31 | [AUDITED FINANCIAL RESULTS FOR THE PERIOD ENDED 31/03/2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cdc019f0-cdab-4772-8ed4-d2c34bc93600.pdf) |
| 2025-02-14 | [Unaudited Financial Results (Consolidated & Standalone) For The Quarter And Nine Months Ended 31/12/2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77e02ed7-d50c-4a93-8676-002b500ef46b.pdf) |
| 2024-11-15 | [Revised Unaudited Financial Results For Period Ended 30.09.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4b47c8dd-c4a9-420e-8592-2a61095df2c4.pdf) |
| 2024-11-14 | [UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30/09/2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7427c64-c6bf-4115-90d5-286dd52c2a2e.pdf) |
| 2024-08-14 | [Un-Audited Financial Results For The Quarter Ended 30/06/2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2713b3e7-266f-4329-9f4e-bda02298b061.pdf) |
| 2024-05-30 | [Audited Financial Results For The Year Ended 31/03/2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aae9b336-715d-4de8-a892-7dca3bb406f0.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8 Apr - Submitted Q4 FY2026 compliance filings, including Regulation 74(5) certificate and share capital audit. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Apr - Submitted Q4 FY2026 compliance filings, including Regulation 74(5) certificate and share capital audit.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5ad9f4ff-ea30-493e-9e00-d93d5bcfe3b5.pdf) |
| 6 Feb - Board meeting Feb 14, 2026 to approve unaudited Q3 results (Dec 31, 2025); trading window closed. | [Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter Ended December 31, 2025 6 Feb - Board meeting Feb 14, 2026 to approve unaudited Q3 results (Dec 31, 2025); trading window closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a293146a-ca61-443b-af77-5581f4c6e2e7.pdf) |
| 5 March 2026 - Investor presentation: Red Herring Prospectus filed for proposed IPO; FY25 revenue ₹8,400 Lakhs; 22,000 MTPA capacity. | [Investor Presentation 5 March 2026 - Investor presentation: Red Herring Prospectus filed for proposed IPO; FY25 revenue ₹8,400 Lakhs; 22,000 MTPA capacity.](https://nsearchives.nseindia.com/corporate/NEOCHEM_05032026180024_Investors_Presentation.pdf) |
| 5 March 2026 - Analyst/Institutional investor meeting on March 10, 2026 at Taj Santacruz, Mumbai (9:00 AM–6:00 PM); no UPSI. | [Analysts/Institutional Investor Meet/Con. Call Updates 5 March 2026 - Analyst/Institutional investor meeting on March 10, 2026 at Taj Santacruz, Mumbai (9:00 AM–6:00 PM); no UPSI.](https://nsearchives.nseindia.com/corporate/NEOCHEM_05032026175540_Intimation_investors_meet_signed.pdf) |
| 31 Dec 2025 - Trading window closed Jan 1, 2026 until 48 hours after announcement of Unaudited Q3 (Dec 31, 2025) results. | [Closure of Trading Window 31 Dec 2025 - Trading window closed Jan 1, 2026 until 48 hours after announcement of Unaudited Q3 (Dec 31, 2025) results.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f8cc97b3-8d9c-4c5a-8628-f9db54ea45dc.pdf) |
| 29 January 2026 - Quarterly investor complaints statement for Dec 31, 2025: one received, one unresolved. | [Integrated Filing- Governance 29 January 2026 - Quarterly investor complaints statement for Dec 31, 2025: one received, one unresolved.](https://nsearchives.nseindia.com/corporate/NEOCHEM_29012026143040_INVESTORs_31122025.pdf) |
| 28 Apr - Srestha Finvest confirms it is not a large corporate as of March 31, 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 28 Apr - Srestha Finvest confirms it is not a large corporate as of March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a392cc0c-a647-4000-9156-81fffcb973df.pdf) |
| 28 Apr - Srestha Finvest confirms it is not a large corporate as of March 31, 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 28 Apr - Srestha Finvest confirms it is not a large corporate as of March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/a392cc0c-a647-4000-9156-81fffcb973df.pdf) |
| 20 January 2026 - NEOCHEM: Corporate governance report under Reg 27(2) not applicable for quarter ended 31 Dec 2025 (EMERGE SME). | [Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter 20 January 2026 - NEOCHEM: Corporate governance report under Reg 27(2) not applicable for quarter ended 31 Dec 2025 (EMERGE SME).](https://nsearchives.nseindia.com/corporate/NEOCHEM_20012026180338_Non_Applicabilty_of_CG_Report.pdf) |
| 18 December 2025 - Neochem states Reg 33 and trading-window rules not applicable for half-year ended 30 Sep 2025; listed Dec 9, 2025. | [Updates 18 December 2025 - Neochem states Reg 33 and trading-window rules not applicable for half-year ended 30 Sep 2025; listed Dec 9, 2025.](https://nsearchives.nseindia.com/corporate/NEOCHEM_18122025200015_INTIMATION-non_applicability[1]__1_.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/46a3788d-318b-4499-af0a-b119d798e0f1.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/570fc60e-77e5-42f4-9585-b10e26451bc2.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/de5f370a-c1ca-4d09-8411-602e3c05c0fb.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/539217/75276539217.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/539217/68830539217.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/539217/65139539217.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/539217/5392170319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/539217/5392170318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/539217/5392170317.pdf) |
| from bse | [Annual Report 2016 from bse](https://www.bseindia.com/bseplus/AnnualReport/539217/5392170316.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:37:40.018Z.